Abstract
Evidence supports a possible role of BANK1 in innate immune signaling in B cells. In the present study, we investigated the interaction of BANK1 with two key mediators in interferon and inflammatory cytokine production, TRAF6 and MyD88. We revealed by coimmunoprecipitation (CoIP) analyses the binding of BANK1 with TRAF6 and MyD88, which were mediated by the BANK1 Toll/interleukin-1 receptor (TIR) domain. In addition, the natural BANK1–40C variant showed increased binding to MyD88. Next, we demonstrated in mouse splenic B cells that BANK1 colocalized with Toll-like receptor (TLR) 7 and TLR9 and that after stimulation with TLR7 and TLR9 agonists, the number of double-positive BANK1–TLR7, –TLR9, –TRAF6, and –MyD88 cells increased. Furthermore, we identified five TRAF6-binding motifs (BMs) in BANK1 and confirmed by point mutations and decoy peptide experiments that the C-terminal domain of BANK1-full-length (-FL) and the N-terminal domain of BANK1–Delta2 (-D2) are necessary for this binding. Functionally, we determined that the absence of the TIR domain in BANK1–D2 is important for its lysine (K)63-linked polyubiquitination and its ability to produce interleukin (IL)-8. Overall, our study describes a specific function of BANK1 in MyD88–TRAF6 innate immune signaling in B cells, clarifies functional differences between the two BANK1 isoforms and explains for the first time a functional link between autoimmune phenotypes including SLE and the naturally occurring BANK1–40C variant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Teruel, M. & Alarcón-Riquelme, M. E. The genetic basis of systemic lupus erythematosus:what are the risk factors and what have we learned. J. Autoimmun. 74, 161–175 (2016).
Ramos-Casals, M., Sanz, I., Bosch, X., Stone, J. H. & Khamashta, M. A. B-cell-depleting therapy in systemic lupus erythematosus. Am. J. Med. 125, 327–336 (2012).
Crampton, S. P., Morawski, P. A. & Bolland, S. Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis. Model Mech. 7, 1033–1046 (2014).
Lee, H.-S. & Bae, S.-C. What can we learn from genetic studies of systemic lupus erythematosus? Implications of genetic heterogeneity among populations in SLE. Lupus 19, 1452–1459 (2010).
Taylor, K. E. et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 7, e1001311 (2011).
Beckwith, H. & Lightstone, L. Rituximab in systemic lupus erythematosus and lupus nephritis. Nephron Clin. Pract. 128, 250–254 (2014).
Liossis, S.-N. C. & Melissaropoulos, K. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments. Expert Opin. Pharm. 15, 833–840 (2014).
Vincent, F. B., Morand, E. F., Schneider, P. & Mackay, F. The BAFF/APRIL system in SLE pathogenesis. Nat. Rev. Rheumatol. 10, 365–373 (2014).
Krieg, A. M. & Vollmer, J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol. Rev. 220, 251–269 (2007).
Theofilopoulos, A. N. et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat. Rev. Rheumatol. 6, 146–156 (2010).
Green, N. M. & Marshak-Rothstein, A. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23, 106–112 (2011).
Hornung, V. et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531–4537 (2002).
Hennessy, E. J., Parker, A. E. & O’Neill, L. A. J. Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9, 293–307 (2010).
Walsh, E. R. et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc. Natl Acad. Sci. USA 109, 16276–16281 (2012).
Jain, S. et al. Interleukin 6 accelerates mortality by promoting the progression of the systemic lupus erythematosus-like disease of BXSB.Yaa mice. PLoS One 11, e0153059 (2016).
Papadimitraki, E. D. et al. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheumatol. 54, 3601–3611 (2006).
Komatsuda, A. et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 152, 482–487 (2008).
Chauhan, S. K., Singh, V. V., Rai, R., Rai, M. & Rai, G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J. Clin. Immunol. 33, 954–964 (2013).
Lyn-Cook, B. D. et al. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol. Immunol. 61, 38–43 (2014).
Christensen, S. R. et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202, 321–331 (2005).
Janssens, S. & Beyaert, R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 27, 474–482 (2002).
Li, L., Cousart, S., Hu, J. & McCall, C. E. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275, 23340–23345 (2000).
Li, S., Strelow, A., Fontana, E. J. & Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl Acad. Sci. USA 99, 5567–5572 (2002).
Walsh, M. C., Lee, J. & Choi, Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol. Rev. 266, 72–92 (2015).
Deng, L. et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361 (2000).
Hofmann, K. & Tschopp, J. The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett. 371, 321–323 (1995).
Hultmark, D. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199, 144–146 (1994).
O’Neill, L. A. J., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors—redefining innate immunity. Nat. Rev. Immunol. 13, 453–460 (2013).
Isnardi, I. et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29, 746–757 (2008).
Rivas, M. N. et al. MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. J. Clin. Investig. 122, 1933–1947 (2012).
Hua, Z. et al. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J. Immunol. 192, 875–885 (2014).
Amos, C. I. et al. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun. 7, 277–286 (2006).
Namjou, B. et al. Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis Rheumatol. 64, 1960–1969 (2012).
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D. V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443–446 (1996).
Chung, J. Y., Park, Y. C., Ye, H. & Wu, H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115, 679–688 (2002).
Ye, H. et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443–447 (2002).
Meads, M. B., Li, Z.-W. & Dalton, W. S. A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit. J. Immunol. 185, 1606–1615 (2010).
Muzio, M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612–1615 (1997).
Inoue, J. et al. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14–24 (2000).
Darnay, B. G., Ni, J., Moore, P. A. & Aggarwal, B. B. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274, 7724–7731 (1999).
Lamothe, B. et al. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283, 24871–24880 (2008).
Kobayashi, T. et al. TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses. PLoS ONE 4, e4736 (2009).
Kozyrev, S. V. et al. Corrigendum: functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40, 484 (2008).
Dieudé, P. et al. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheumatol. 60, 3447–3454 (2009).
Orozco, G. et al. Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis Rheumatol. 60, 372–379 (2009).
Suarez-Gestal, M. et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheumatol. 60, 2558–2564 (2009).
Troutman, T. D. et al. Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc. Natl Acad. Sci. USA 109, 273–278 (2012).
Kozyrev, S. V., Bernal-Quirós, M., Alarcón-Riquelme, M. E. & Castillejo-López, C. The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization. Genes Immun. 13, 129–138 (2012).
Yokoyama, K. et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. EMBO J. 21, 83–92 (2002).
Aiba, Y. et al. BANK negatively regulates akt activation and subsequent B cell responses. Immunity 24, 259–268 (2006).
Dam, E. M. et al. The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans. Clin. Immunol. 173, 171–180 (2016).
Wu, Y.-Y., Kumar, R., Haque, M. S., Castillejo-Lopez, C. & Alarcon-Riquelme, M. E. BANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1/2/eIF4E translation initiation pathway. J. Immunol. 191, 6110–6116 (2013).
Wu, Y.-Y., Kumar, R., Iida, R., Bagavant, H. & Alarcón-Riquelme, M. E. BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation. PLoS One 11, e0156302 (2016).
Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308–311 (2001).
Jiang, S. H. et al. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus. Nat Commun 10, 2201 (2019).
Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061–1068 (2004).
Bernal-Quirós, M., Wu, Y.-Y., Alarcón-Riquelme, M. E. & Castillejo-López, C. BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling. PLoS ONE 8, e59842 (2013).
Yen, H.-C. S., Xu, Q., Chou, D. M., Zhao, Z. & Elledge, S. J. Global protein stability profiling in mammalian cells. Science 322, 918–923 (2008).
Halabi, S., Sekine, E., Verstak, B., Gay, N. J. & Moncrieffe, M. C. Structure of the Toll/Interleukin-1 receptor (TIR) domain of the B-cell adaptor that links phosphoinositide metabolism with the negative regulation of the Toll-like receptor (TLR) signalosome. J. Biol. Chem. 292, 652–660 (2017).
Martínez-Bueno, M. et al. Trans-ethnic mapping of BANK1 identifies two independent SLE-risk linkage groups enriched for co-transcriptional splicing marks. Int. J. Mol. Sci. 19, https://doi.org/10.3390/ijms19082331 (2018).
Into, T., Inomata, M., Niida, S., Murakami, Y. & Shibata, K. Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6. J. Biol. Chem. 285, 35759–35769 (2010).
Kawai, T. & Akira, S. TLR signaling. Cell Death Differ. 13, 816–825 (2006).
Lim, K. L. et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25, 2002–2009 (2005).
Acknowledgements
We wish to thank the Unit of Microscopy and Flow Cytometry of GENYO for their constant help and support during experiments. This work was supported by the MINECO and cofinanced by the FEDER funds of the European Union [SAF2016-78631-P entitled “The Role of BANK1 in B Cell signaling through TLRs and autoimmunity”]; by the Swedish Research Council of Medicine to M.E.A.R.; by the Instituto de Salud Carlos III grant to I.G. [CD11/00277]; by the Proyecto de Excelencia, Consejería de Economía, Innovación y Ciencia of Andalucía [CTS-2548]; and by the Fundación Ramón Areces.
Author information
Authors and Affiliations
Contributions
I.G. designed, analyzed, and provided overall guidance for the experiments and wrote the manuscript. A.D.B. designed, performed, and analyzed the experiments and wrote the manuscript. M.M. assisted with and performed experiments that involved mice. A.L.P. helped design the decoy peptide experiments. M.E.A.R. proposed the project, supervised the performance of the experiments and their analyses, revised the manuscript, and led the project.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Georg, I., Díaz-Barreiro, A., Morell, M. et al. BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells. Cell Mol Immunol 17, 954–965 (2020). https://doi.org/10.1038/s41423-019-0254-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-019-0254-9
Keywords
This article is cited by
-
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
Molecular and Cellular Pediatrics (2023)
-
A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren’s Syndrome
Clinical Reviews in Allergy & Immunology (2022)
-
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment
Nature Communications (2022)
-
Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus
Inflammation Research (2021)
-
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals
Current Rheumatology Reports (2021)